October 18, 2025
Long-Term Data Support Early GA Intervention
New data from the GATHER2 open-label extension, presented during retina subspecialty day at AAO, emphasizes the value of starting treatment early to preserve retinal tissue.
2025 American Academy of Ophthalmology Annual Meeting
Related Articles
October 18, 2025
Intravitreal Methotrexate Formulation Lowers Postoperative Complications
GUARD trial data presented at AAO show that adjunctive ADX-2191 is linked to reduced rates of hypotony and cystoid macular edema in PVR surgery.
October 18, 2025
Avoiding Radiation in Uveal Melanoma
Findings presented at AAO 2025 demonstrated that treatment with ablation and anti-VEGF injections allowed patients to avoid radiation-related damage, with most maintaining 20/40 vision or better.
October 18, 2025
Sura Vec Shows Promise in NPDR
Two-year ALTITUDE data presented during AAO’s retina subspecialty day showed that the suprachoroidal anti-VEGF gene therapy achieved sustained DRSS gains with acceptable safety.
October 18, 2025
The Utility of Home OCT
During retina subspecialty day at AAO 2025, Anat Loewenstein, MD, outlined practical applications of home OCT.
October 18, 2025
No More Tech Neck: Ergonomics That Work for Retinal Surgeons
At AAO 2025, Christina Y. Weng, MD, MBA, shared practical strategies to reduce neck, back, and upper-body strain for retina specialists.